Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An automated method for dynamic ligand design

A Miranker1, M Karplus

  • 1Department of Chemistry, Harvard University, Cambridge Massachusetts 02138, USA.

Proteins
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

All-atom empirical potential for molecular modeling and dynamics studies of proteins.

The journal of physical chemistry. B·2014
Same author

A conformational transition in the myosin VI converter contributes to the variable step size.

Biophysical journal·2011
Same author

Calculation of free-energy differences by confinement simulations. Application to peptide conformers.

The journal of physical chemistry. B·2009
Same author

CHARMM: the biomolecular simulation program.

Journal of computational chemistry·2009
Same author

Molecular dynamics studies of NMR relaxation in proteins.

Biophysical journal·2009
Same author

Protein-Protein Interactions in DNA Recognition: H-NMR Studies of Lambda cI Repressors Genetically Altered by Site-Directed Mutagenesis.

Biophysical journal·2009
Same journal

Engineered HSP90-MP65 Bivalent Fusion Antigen: A Novel Vaccine Candidate Against Invasive Candidiasis.

Proteins·2026
Same journal

Physics-Based Energy Functions for Computational Protein Design.

Proteins·2026
Same journal

Impact of Stabilizing Osmolytes on the Conformational Dynamics of Human and Rat Islet Amyloid Polypeptides.

Proteins·2026
Same journal

Stabilization of Bone Morphogenetic Protein-2 at Physiological pH: Contrasting Roles of CHAPS and Arginine in Aggregation Inhibition.

Proteins·2026
Same journal

Structural Insights Into the Function of Leishmania major Adenylosuccinate Lyase.

Proteins·2026
Same journal

Generalizing the Gaussian Network Model: Spanning-Tree Thermodynamics Shows Entropy-Driven KRAS Activation.

Proteins·2026
See all related articles

This study introduces dynamic ligand design (DLD), an automated method for creating novel or modifying existing drug molecules. DLD optimizes ligands to perfectly fit target binding sites, advancing drug discovery.

Area of Science:

  • Computational Chemistry
  • Structural Biology
  • Drug Discovery

Background:

  • Designing ligands with high affinity and specificity for protein binding sites is crucial for drug development.
  • Existing methods often require significant manual intervention and computational resources.
  • Automating ligand design can accelerate the discovery of novel therapeutic agents.

Purpose of the Study:

  • To present an automated method for dynamic ligand design (DLD) applicable to binding sites of known structures.
  • To enable the creation of de novo ligands and the modification of existing ones.
  • To demonstrate the method's efficacy using the FK506 binding protein (FKBP) as a model system.

Main Methods:

  • The binding site is filled with atoms that form molecules guided by a potential function ensuring correct stereochemistry.

Related Experiment Videos

  • A generalized potential function allows atoms to explore continuous parameter spaces, including coordinates, occupancy, and type.
  • Molecules are generated and optimized using Monte Carlo simulated annealing within the defined parameter space.
  • The method links generated molecules to precomputed functional group positions within the binding site.

    • Main Results:

    • The DLD method successfully designed de novo ligands for the FKBP binding site.
    • Modifications to the immunosuppressant drug FK506 were proposed.
    • The designed ligands demonstrated complementarity to both the shape and charge distribution of the FKBP binding site.
    • The approach showcases the potential for automated, structure-based ligand generation.

    Conclusions:

    • The dynamic ligand design approach offers an automated and efficient strategy for generating novel and optimized ligands.
    • This method can significantly aid in the design of molecules that precisely fit target binding sites.
    • DLD has broad applicability in drug discovery for both de novo design and lead optimization.